Teva Pharmaceutical Industries has introduced an authorized generic of ACTOplus met (pioglitazone/metformin tablets) 15mg/500mg, 15mg/850mg.
ACTOplus met is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes.
According to IMS sales data, ACTOplus met had annual sales of approximately $413m in the US as of 30 June 2012.
Teva Pharmaceutical Industries produces and markets generic drugs as well as specialty pharmaceuticals and active pharmaceutical ingredients.
Source:
http://drugdiscovery.pharmaceutical-business-review.com/news/teva-introduces-generic-actoplus-met-200812
